Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01659541 · ClinicalTrials.gov registry record · NA

Stimulation With Wire Leads to Restore Cough

A NA study of Spinal Cord Injuries and Wounds and Injuries, sponsored by MetroHealth Medical Center.

Completed
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT01659541 is a NA study of Spinal Cord Injuries and Wounds and Injuries that has completed, run by MetroHealth Medical Center. The registered enrollment target is 12 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01659541, a NA study of Spinal Cord Injuries and Wounds and Injuries, has completed, sponsored by MetroHealth Medical Center.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of this trial is to determine the efficacy of spinal cord stimulation, using wire leads, to produce an effective cough in patients with spinal cord injuries.

Interventions

  • DEVICE Expiratory muscle stimulator
  • PROCEDURE Implantation of device

Study Locations (1)

Ohio

  • MetroHealth Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2015-04
Est. Completion 2021-07-31
Phase NA

Sponsor

MetroHealth Medical Center

76 total trials

What the Registry Record Tells You About NCT01659541

The ClinicalTrials.gov registry entry for NCT01659541 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (81% lower). The listed sponsor is MetroHealth Medical Center, which has 76 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 2 interventions - of which Expiratory muscle stimulator is the first listed.

NCT01659541 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01659541 about?

NCT01659541 is a clinical study titled "Stimulation With Wire Leads to Restore Cough". The purpose of this trial is to determine the efficacy of spinal cord stimulation, using wire leads, to produce an effective cough in patients with spinal cord injuries.

What is the current status of trial NCT01659541?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-04. Estimated completion is 2021-07-31.

What conditions does trial NCT01659541 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Wounds and Injuries, Central Nervous System Diseases, Paralysis, Cough.

What interventions are being tested in trial NCT01659541?

The interventions under investigation include: Expiratory muscle stimulator (DEVICE), Implantation of device (PROCEDURE).

Who is sponsoring clinical trial NCT01659541?

This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01659541 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.